|
Bill focuses on enterprise companies and technologies for Greylock, a private equity venture capital firm founded in 1965. Having joined Greylock in 1984, Mr. Helman serves in the role of general partner. Bill also led Greylock�s investments in Exact Sciences (EXAS), Tessera (merged with iXL), Ontogeny, Hyperion Software, Filene�s Basement, Pharmacopeia (PCOP), Millennium Pharmaceuticals (MLNM), Staples.com (acquired by Staples), and Vertex Pharmaceuticals (VRTX). In addition to representing Greylock on the Board of Directors for CentrePath, he also is a member of the Board for Incipient, iPhrase, netNumina, OATSystems, OutlookSoft, Reveal, Upromise, and Vettro. He is a graduate of Dartmouth College and the Harvard Business School. | 